Polynucleotides, vectors and methods for insertion and expression of transgenes
Embodiments herein include polynucleotides, vectors and methods for the insertion and expression of transgenes. In an embodiment, a polynucleotide is included. The polynucleotide can include a JeT promoter or variant thereof, an intron sequence less than 400 bases in length, and a polynucleotide sequence encoding a polypeptide or protein operatively linked to the promoter. In an embodiment, a recombinant vector is included. The recombinant vector can include a JeT promoter or variant thereof, an intron sequence less than 400 bases in length, and a polynucleotide sequence encoding a polypeptide or protein operatively linked to the promoter. Other embodiments are also included herein.
1. A polynucleotide, comprising:
a JeT promoter or variant thereof,
a synthetic intron sequence less than 400 bases in length, the intron sequence having at least 90% sequence identity to SEQ ID NO: 11; and
a polynucleotide sequence encoding a polypeptide or protein, the sequence operatively linked to the promoter.
2. The polynucleotide of claim 1 , wherein the JeT promoter or variant thereof has at least 90% sequence identity to a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 8, or SEQ ID NO: 10.
3. The polynucleotide of claim 1 , wherein the JeT promoter or variant thereof has at least 90% sequence identity to at least one of SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16 in the JeT promoter sequence from −36 to +42 relative to the transcription start site (Inr).
4. The polynucleotide of claim 1 , wherein the JeT promoter or variant thereof has at least 99% sequence identity to at least one of SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16 in the JeT promoter sequence from −36 to +42 relative to the transcription start site (Inr).
5. The polynucleotide of claim 1 , wherein the JeT promoter or variant thereof has the nucleotides CT at locations +16 and +17 from the Inr A+1 transcription initiation site.
6. The polynucleotide of claim 1 , the polypeptide or protein comprising a β-hexosaminidase protein, a subunit thereof, or a variant thereof.
7. The polynucleotide of claim 1 , wherein the polynucleotide sequence encoding a polypeptide or protein is less than about 4.0 kilobases in length.
8. The polynucleotide of claim 1 , wherein the polynucleotide sequence encoding a polypeptide or protein is between 1.2 and 2.0 kilobases in length.
9. The polynucleotide of claim 1 , wherein the polynucleotide sequence encodes a polypeptide having at least 80% sequence identity to residues 89-529 of the alpha-subunit of Hex A (SEQ ID NO: 9) or conservative variants thereof.
10. A transgene expression system comprising
(a) a polynucleotide sequence comprising a transgene operably linked to a JeT promoter, or variant thereof, and a synthetic intron sequence of less than 400 bases in length, the intron sequence having at least 90% sequence identity to SEQ ID NO: 11; and
(b) a viral vector carrying the polynucleotide sequence.
11. The transgene expression system of claim 10 , the viral vector comprising an adeno-associated virus (AAV) vector.
12. The transgene expression system of claim 10 , wherein the JeT promoter or variant thereof has at least 90% sequence identity to a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 8, or SEQ ID NO: 10.
13. The transgene expression system of claim 10 , the transgene coding for a β-hexosaminidase protein, a subunit thereof, or a variant thereof.
14. The transgene expression system of claim 10 , the transgene encoding a polypeptide having at least 80% sequence identity to residues 89-529 of the alpha-subunit of Hex A (SEQ ID NO: 9) or conservative variants thereof.
15. The polynucleotide of claim 1 , the intron sequence having at least 98% sequence identity to SEQ ID NO: 11.
16. The polynucleotide of claim 1 , the intron sequence comprising SEQ ID NO: 11.
17. A polynucleotide, comprising:
a JeT promoter or variant thereof, wherein the JeT promoter or variant thereof has at least 90% sequence identity to a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 8, or SEQ ID NO: 10,
a synthetic intron sequence less than 400 bases in length, and
a polynucleotide sequence encoding a polypeptide or protein, the sequence operatively linked to the promoter.
18. The polynucleotide of claim 17 , the polypeptide or protein comprising a β-hexosaminidase protein, a subunit thereof, or a variant thereof.
19. A transgene expression system comprising:
(a) a polynucleotide sequence comprising a transgene operably linked to a JeT promoter, or variant thereof, wherein the JeT promoter or variant thereof has at least 90% sequence identity to a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 8, or SEQ ID NO: 10, and a synthetic intron sequence of less than 400 bases in length; and
(b) a viral vector carrying the polynucleotide sequence.
20. The transgene expression system of claim 19 , the viral vector comprising an adeno-associated virus (AAV) vector.